ALLR- Low Conviction High Upside

Got in at $0.798 average.

globenewswire.com/news-release/2024/05/02/2874113/0/en/Allarity-Therapeutics-Stenoparib-Shows-Clear-Clinical-Benefit-and-Achieves-Significant-Milestone-with-Early-Conclusion-of-Phase-2-Trial-in-Advanced-Ovarian-Cancer.html

globenewswire.com/news-release/2024/05/07/2876853/0/en/Allarity-Therapeutics-Announces-that-All-Series-A-Preferred-and-All-Variable-Priced-Warrants-have-Converted-to-Common-Stock.html